key: cord-0764701-5sduqqcu authors: Damiani, Giovanni; Gironi, Laura Cristina; Kridin, Khalaf; Pacifico, Alessia; Buja, Alessandra; Bragazzi, Nicola Luigi; Spalkowska, Magdalena; Pigatto, Paolo Daniele Maria; Santus, Pierachille; Savoia, Paola title: Mask‐induced Koebner phenomenon and its clinical phenotypes: A multicenter, real‐life study focusing on 873 dermatological consultations during COVID‐19 pandemics date: 2021-02-08 journal: Dermatol Ther DOI: 10.1111/dth.14823 sha: 6c00962787dcc9459eedb574b4c24e63f858f2a9 doc_id: 764701 cord_uid: 5sduqqcu During COVID‐19 pandemic, wearing masks for prevention became mandatory but evidence suggest that is also detrimental for skin. Although facial dermatoses due to masks increase in both healthcare workers and general population, a pathogenetic hypothesis remains still elusive. We aimed to evaluate the prevalence of dermatological consultations due to Koebner triggered dermatoses In this prospective, multicenter, real life study carried out in Italy from March 11th to December 11th 2020 during COVID‐19 pandemics, dermatological consultations (in‐person and telemedicine) to study the prevalence of Koebner (KB) phenomenon due to masks were evaluated. Boyd and Nelder classification was adopted for Koebner phenomenon and Bizzozero's for KB intensity. A total of 229/873 (26.2%) dermatological consultations were KB triggered dermatoses and lesions were located in mask‐covered ear area (76 [33.2%]), malar area (73 [31.8%]), perioral area (53 [23.1%]), and nose (27 [11.8%]). The first KB category grouped 142 patients (psoriasis, vitiligo, maskne, and mask rosacea), the second one 24 (warts, molluscum contagiosum, and impetigo), the third one 46 (atopic dermatitis), and the fourth one 17 (eczema). Among previously KB negative psoriatic patients that became KB positive, 9/13 (69.2%) had discontinued or modified the prescribed antipsoriatic treatment. Mask‐related Koebner phenomenon is an important clinical sign to orient clinician's therapeutic protocols during COVID‐19 pandemic, especially in patients with psoriasis. During COVID-19 pandemics, overwhelmed healthcare systems promoted self-preventive strategies to avoid SARSCoV-2 infection, spacing from lockdown to mask wearing. [1] [2] [3] Dermatology departments worldwide reprioritized visits and improved telemedicine consultation in both primary and follow up visits. [4] [5] [6] Wearing masks became mandatory initially for healthcare workers and after also for civilians, 7 changing skin exposure and the whole facial exposome. 8 Despite hypotheses multiplied, the pathogenetic mechanism of mask-induced dermatoses remains elusive. Masks short-term and long-term wearing for preventive exigencies are also changing the dermato-epidemiology, 9, 10 forcing dermatologists to integrate guidelines based on evidence. 11 Recently, Mutalik et al described a Koebner phenomenon (KB) due to mask in a 74 years old patient with psoriasis, rising the possibility that mask via KB may worsen preexisting facial dermatoses. 12 Thus, we decided to perform a study focusing on mask-induced Koebner phenomenon on patients referred to dermatology during COVID-19 pandemic. This is a prospective, multicenter, real life study that involved three primary referral dermatological centers in Italy (IRCCS Istituto Ortopedico Galeazzi, IRCCS San Gallicano and Maggiore della Carità) carried out from March 11th to December 11th 2020 during COVID-19 pandemics. Dermatological consultations (in-person and telemedicine) were recorded to understand the role of masks in triggering Koebner phenomenon. Telemedicine video calls were performed with different platforms (FaceTime, WhatsApp, Skype, Zoom, or Go-to-Meeting), depending from patients preferences, and lasted 15 minutes. To assess Koebner phenomenon we adopted Boyd and Nelder' classification, 12 summarized in Table 1. In line with Bizzozzero et al, 14 KB intensity was rated as "maximal" for lesions developed across the entire mask covered area, "minimal" for lesions developed in focal areas covered by mask, "abortive" for lesions vanishing spontaneously in 12-20 days, and "none" for absence of lesions. Koebner phenomenon was clinically and dermatoscopically differentiated from "patergy" since new lesions appearing on unaffected skin were specific of facial preexistent dermatoses, whilst medical history contributed to differentiate KB from "reverse KB" (existing lesions that disappear after trauma) and "Wolf's isotopic response" (lesions appear after a trauma and anticipate the dermatosis occurrence). 15 Coherently with the nosologic definition, we defined maskne/ mask rosacea as koebnerized dermatoses only if the acne/rosacea worsened in areas mask-covered after regular mask wearing. 16 Patients with rosacea underwent patch tests 17 to rule out a possible concurrent allergic contact dermatitis due to mask release of formaldehyde. 18 Demographics (age, gender) and clinical data (dermatoses severity, medical history, and drug intakes) were carefully recorded together with mask related data (prevalent mask wearing model and daily mask wearing duration). Dermatoses severity indexes adopted in this study are: Psoriasis Area Severity Index (PASI) for psoriasis, 19 Vitiligo Area Scoring Index (VASI) for vitiligo patients, 20 Global Acne Grading Scale (GAGS) for maskne patients, 21 Investigator Global Assessment (IGA) for mask rosacea, and impetigo patients, 22 Eczema Area and Severity Index (EASI) for patients with both atopic dermatitis and eczema. 23 Normal distribution for each variable was investigated by performing the Kolmogorov-Smirnov test. Data were reported as mean ± SD or median Masks during COVID-19 pandemic trigger both de novo dermatoses 10 and also worsen pre-existing ones; mask-covered areas are exposed to proinflammatory microenvironment 8 Maskne (acne due to mask) and mask rosacea are classified as "true Koebner" since our current understanding is that the inflamed pilosebaceous units are further influenced by mask-related microenvironment and mask-related mechanic traumas, as hypothesized for vitiligo KB mask-related. 16 Masks also cause itch 32, 33 and scratching derived injuries, the exact pseudo Koebner pathogenesis capable to explain KB related impetigo, warts, and molluscum contagiosum. Third and fourth Boyd and Nelder' categories are communed by the cutaneous barrier defects that further amplify mask-derived inflammation. Despite its innovative evaluation in assessing Koebner phenomenon due to masks, our study present also the limitation that telemedicine consultations were performed with several video call platforms with a resolution dependent from patient's line and device. Furthermore, due to the limited patients sample for every single dermatosis, it was not possible to evaluate the influence of mask type and donning duration in triggering KB in each dermatosis evaluated. In conclusion, mask-related Koebner phenomenon is an important clinical sign to orient clinician's therapeutic protocols, especially in patients with psoriasis and vitiligo. Further studies and big data 34 are needed to understand in detail the immunological changes induced by masks. Italy's health performance, 1990-2017: findings from the global burden of disease study 2017 Safe distance, safe patients! Therapeutic management of oncological patients affected by cutaneous and mucosal adverse events during the COVID-19 pandemic: an Italian experience Dermatologists and SARS-CoV-2: the impact of the pandemic on daily practice Priorities for global health community in COVID-19 pandemic The impact of COVID-19 pandemics on dermatologic surgery: real-life data from the Italian redzone Phototherapeutic approach to dermatology patients during the 2019 coronavirus pandemic: real-life data from the Italian red zone A rapid review of the use of face mask in preventing the spread of COVID-19 Short-term skin reactions following use of N95 respirators and medical masks The burden of skin and subcutaneous diseases in the United States from 1990 to 2017 Prevención de lesiones cutáneas causadas por productos y equipos de protección personal durante COVID-19: revisión de alcance Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis suppurativa, and acne/rosacea during the COVID-19 pandemic Mask-induced psoriasis lesions as Köebner phenomenon during COVID-19 pandemic The isomorphic response of Koebner Diagnostic and management considerations for 'Maskne' in the era of COVID-19 Professionale e Ambientale) Italian guidelines in patch testing: adapted from the European Society of Contact Dermatitis (ESCD) Surgical mask dermatitis caused by formaldehyde (releasers) during the COVID-19 pandemic Severe psoriasis-oral therapy with a new retinoid Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the vitiligo area scoring index Scoring systems in acne vulgaris Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society expert committee The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis (EASI Evaluator Group) Response to injury of skin involved and uninvolved with psoriasis, and its relation to disease activity: Koebner and 'reverse' Koebner reactions Koebner phenomenon leading to the formation of new psoriatic lesions: evidences and mechanisms The metabolomics of psoriatic disease Genome-wide DNA methylation profiling identifies differential methylation in uninvolved psoriatic epidermis COVID-19 knowledge prevents biologics discontinuation: data from an Italian multicenter survey during RED-ZONE declaration Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: real-life data from a large cohort during red-zone declaration Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: a northern Italy experience Clinical significance of Koebner phenomenon in vitiligo Increased prevalence of face mask-induced itch in health care workers The effects of the face mask on the skin underneath: a prospective survey during the COVID-19 pandemic How big data and artificial intelligence can help better manage the COVID-19 pandemic